PortfoliosLab logoPortfoliosLab logo
IBRN vs. SPAQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IBRN vs. SPAQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Neuroscience and Healthcare ETF (IBRN) and Horizon Kinetics SPAC Active ETF (SPAQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBRN achieves a 14.14% return, which is significantly higher than SPAQ's 3.35% return.


IBRN

1D
0.60%
1M
6.49%
YTD
14.14%
6M
14.25%
1Y
71.08%
3Y*
14.72%
5Y*
10Y*

SPAQ

1D
-0.20%
1M
1.41%
YTD
3.35%
6M
2.27%
1Y
4.10%
3Y*
5.98%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBRN vs. SPAQ - Yearly Performance Comparison


2026 (YTD)202520242023
IBRN
iShares Neuroscience and Healthcare ETF
14.14%28.49%-2.78%-3.34%
SPAQ
Horizon Kinetics SPAC Active ETF
3.35%7.35%4.33%5.32%

Correlation

The correlation between IBRN and SPAQ is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.03

Correlation (All Time)
Calculated using the full available price history since Jan 30, 2023

0.03

IBRN vs. SPAQ - Sectors Allocation Comparison


Sectors
IBRN
SPAQ

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

100.0%

Industrials

-

0.1%

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

IBRN
100.0%
SPAQ

-

Basic Materials

IBRN

-

SPAQ

-

Communication Services

IBRN

-

SPAQ

-

Consumer Cyclical

IBRN

-

SPAQ

-

Consumer Defensive

IBRN

-

SPAQ

-

Energy

IBRN

-

SPAQ

-

Financial Services

IBRN

-

SPAQ
100.0%

Industrials

IBRN

-

SPAQ
0.1%

Real Estate

IBRN

-

SPAQ

-

Technology

IBRN

-

SPAQ

-

Utilities

IBRN

-

SPAQ

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBRN vs. SPAQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRN
IBRN Risk / Return Rank: 8989
Overall Rank
IBRN Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
IBRN Sortino Ratio Rank: 8888
Sortino Ratio Rank
IBRN Omega Ratio Rank: 8080
Omega Ratio Rank
IBRN Calmar Ratio Rank: 9696
Calmar Ratio Rank
IBRN Martin Ratio Rank: 9393
Martin Ratio Rank

SPAQ
SPAQ Risk / Return Rank: 1818
Overall Rank
SPAQ Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
SPAQ Sortino Ratio Rank: 1515
Sortino Ratio Rank
SPAQ Omega Ratio Rank: 1717
Omega Ratio Rank
SPAQ Calmar Ratio Rank: 1919
Calmar Ratio Rank
SPAQ Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBRN vs. SPAQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Neuroscience and Healthcare ETF (IBRN) and Horizon Kinetics SPAC Active ETF (SPAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IBRNSPAQDifference
Sharpe ratioReturn per unit of total volatility

+2.33

Sortino ratioReturn per unit of downside risk

+3.00

Omega ratioGain probability vs. loss probability

1.43

1.11

+0.32

Calmar ratioReturn relative to maximum drawdown

8.12

0.82

+7.29

Martin ratioReturn relative to average drawdown

22.92

2.97

+19.95

IBRN vs. SPAQ - Sharpe Ratio Comparison

The current IBRN Sharpe Ratio is 2.80, which is higher than the SPAQ Sharpe Ratio of 0.48. The chart below compares the historical Sharpe Ratios of IBRN and SPAQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IBRN vs. SPAQ - Drawdown Comparison

The maximum IBRN drawdown since its inception was -35.38%, which is greater than SPAQ's maximum drawdown of -5.30%. Use the drawdown chart below to compare losses from any high point for IBRN and SPAQ.


Loading charts...

Drawdown Indicators


IBRNSPAQDifference

Max Drawdown

Largest peak-to-trough decline

-35.38%

-5.30%

-30.08%

Max Drawdown (1Y)

Largest decline over 1 year

-8.80%

-5.00%

-3.80%

Max Drawdown (3Y)

Largest decline over 3 years

-35.38%

-5.30%

-30.08%

Current Drawdown

Current decline from peak

0.00%

-0.32%

+0.32%

Average Drawdown

Average peak-to-trough decline

-9.75%

-0.53%

-9.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.11%

1.39%

+1.72%

Volatility

IBRN vs. SPAQ - Volatility Comparison

iShares Neuroscience and Healthcare ETF (IBRN) has a higher volatility of 8.17% compared to Horizon Kinetics SPAC Active ETF (SPAQ) at 1.02%. This indicates that IBRN's price experiences larger fluctuations and is considered to be riskier than SPAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBRNSPAQDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.17%

1.02%

+7.15%

Volatility (6M)

Calculated over the trailing 6-month period

19.20%

5.06%

+14.14%

Volatility (1Y)

Calculated over the trailing 1-year period

25.50%

8.65%

+16.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.36%

6.96%

+18.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.36%

6.96%

+18.40%

IBRN vs. SPAQ - Expense Ratio Comparison

IBRN has a 0.47% expense ratio, which is lower than SPAQ's 0.85% expense ratio.


Dividends

IBRN vs. SPAQ - Dividend Comparison

IBRN's dividend yield for the trailing twelve months is around 0.87%, less than SPAQ's 16.15% yield.


PositionTTM202520242023
IBRN
iShares Neuroscience and Healthcare ETF
0.87%0.99%0.40%0.06%
SPAQ
Horizon Kinetics SPAC Active ETF
16.15%16.69%3.00%2.60%

Frequently Asked Questions


IBRN and SPAQ have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBRN has higher volatility (8.17%) compared to SPAQ (1.02%). In terms of maximum drawdown, IBRN dropped -35.38% vs SPAQ's -5.30%.

On 3-year performance, IBRN leads with 14.72% vs 5.98% for SPAQ. On fees, IBRN is cheaper at 0.47% per year. On volatility, SPAQ has been the lower-risk option at 1.02%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, IBRN has performed better with a 14.72% return vs 5.98%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IBRN is cheaper with a 0.47% expense ratio, compared with 0.85% for SPAQ.

SPAQ has the higher dividend yield at 16.15%, compared with 0.87% for IBRN.

They also come from different issuers: iShares and Horizon. Their fees differ too: 0.47% for IBRN and 0.85% for SPAQ.

IBRN currently has the higher Sharpe Ratio (2.80 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBRN and SPAQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer